Related Experiment Video
Updated: Jul 5, 2025
14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
The pathogenesis of Parkinson's disease.
Huw R Morris1, Maria Grazia Spillantini2, Carolyn M Sue3
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK; University College London Movement Disorders Centre, University College London, London, UK; Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD, USA.
Lancet (London, England)
|January 20, 2024
Summary
Parkinson's disease involves alpha-synuclein aggregation and spreading, impacting cellular functions and immune responses. Research provides a basis for developing neuroprotective therapies to halt disease progression.
Area of Science:
- Neuroscience
- Pathology
- Genetics
Background:
- Parkinson's disease is a progressive neurodegenerative disorder characterized by aggregated alpha-synuclein.
- Understanding its pathogenesis involves genetics, molecular pathology, and cellular mechanisms.
Purpose of the Study:
- To review current insights into Parkinson's disease pathogenesis.
- To explore potential therapeutic strategies based on cellular and molecular findings.
Main Methods:
- Review of genetic and molecular pathology studies.
- Analysis of biochemical studies, transplanted neuron investigations, and cell/animal models.
- Examination of cellular functions (mitochondrial, lysosomal, endosomal) and immune responses.
Main Results:
- Abnormal alpha-synuclein aggregation and its spread (gut-brain axis) are implicated in disease development.
- Cellular dysfunctions (mitochondria, lysosomes, endosomes) are observed in both genetic and sporadic forms.
- Immune and inflammatory responses, potentially gut-initiated, accelerate Parkinson's pathogenesis.
Conclusions:
- Current research offers a foundation for developing neuroprotective therapies.
- The goal is to halt the progression of Parkinson's disease.
- No disease-modifying treatments are currently available, but rational therapeutic development is promising.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
01:24Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K